Table 3.
Gender | Age | Disease duration | BMF—total | BMF—motor | BMF—disability | Eq-5D | |
---|---|---|---|---|---|---|---|
Pt 1 | F | 45 | 26 | 24 | 14 | 10 | 20 |
Pt 2 | F | 67 | 14 | 44 | 32 | 12 | 30 |
Pt 3 | M | 58 | 8 | 46 | 31 | 15 | 25 |
Pt 4 | M | 49 | 35 | 42 | 28 | 14 | 15 |
Pt 5 | M | 70 | 40 | 31 | 20 | 11 | 20 |
Pt 6a | M | 64a | 12a | 32a | 18a | 14a | 20a |
Pt 7 | F | 75 | 4 | 40 | 29 | 11 | 20 |
Pt 8 | F | 68 | 37 | 20 | 15 | 5 | 40 |
Pt 9b | F | 48b | 18b | 31b | 20b | 11b | 25b |
Mean | 60.44 | 27.5 | 34.44 | 23.00 | 11.44 | 23.89 | |
SD | 10.88 | 13.44 | 9.08 | 7.02 | 2.96 | 7.41 |
Mean values and Standard Deviation (SD) are highlighted in bold, italic
aPatient underwent GPi + VIM implant after removal of previously implanted VIM leads
bPatient underwent VIM implant but had a pre-existing GPi, active since 2012